Wilson disease: a summary of the updated AASLD Practice Guidance

por Alkhouri, Naim, Gonzalez-Peralta, Regino P., Medici, Valentina
Publicado 2023

Isoniazid-Induced Severe Hepatotoxicity: An Infrequent but Preventable Cause of Liver Failure in Children Treated for Latent Tuberculosis Infection

por Desrochers, Dan, González-Peralta, Regino P., McClenathan, Daniel T., Wilsey, Michael J., Haafiz, Allah
Publicado 2011

Elevated Alkaline Phosphatase in Children: An Algorithm to Determine When a “Wait and See” Approach is Optimal

por Otero, Jaclyn L., González-Peralta, Regino P., Andres, Joel M., Jolley, Christopher D., Novak, Don A., Haafiz, Allah
Publicado 2011

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4

por Leung, Daniel H., Wirth, Stefan, Yao, Betty B., Viani, Rolando M., Gonzalez‐Peralta, Regino P., Jonas, Maureen M., Lobritto, Steven J., Narkewicz, Michael R., Sokal, Etienne, Fortuny, Clàudia, Hsu, Evelyn K., Del Valle‐Segarra, Antonio, Zha, Jiuhong, Larsen, Lois, Liu, Li, Shuster, Diana L., Cohen, Daniel E., Rosenthal, Philip
Publicado 2018

Elbasvir/grazoprevir in children aged 3–18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study

por Gonzalez-Peralta, Regino P., Wirth, Stefan, Squires, Robert H., Mutschler, Frauke, Lang, Thomas, Pawlowska, Malgorzata, Sluzewski, Wojciech, Majda-Stanislawska, Ewa, Fischler, Bjorn, Balistreri, William F., Jonas, Maureen M., Blondet, Niviann, Rosenthal, Philip, Alkhouri, Naim, Romero, Rene, Grandhi, Anjana, Castronuovo, Patricia, Caro, Luzelena, Du, Lihong, Rosenbloom, Daniel I.S., Haber, Barbara A.
Publicado 2023

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study

por Jonas, Maureen M., Rhee, Susan, Kelly, Deirdre A., Del Valle‐Segarra, Antonio, Feiterna‐Sperling, Cornelia, Gilmour, Susan, Gonzalez‐Peralta, Regino P., Hierro, Loreto, Leung, Daniel H., Ling, Simon C., Lobzin, Yuri, Lobritto, Steven, Mizuochi, Tatsuki, Narkewicz, Michael R., Sabharwal, Vishakha, Wen, Jessica, Kei Lon, Hoi, Marcinak, John, Topp, Andrew, Tripathi, Rakesh, Sokal, Etienne
Publicado 2021

Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection

por Rosenthal, Philip, Schwarz, Kathleen B., Gonzalez‐Peralta, Regino P., Lin, Chuan‐Hao, Kelly, Deidre A., Nightingale, Scott, Balistreri, William F., Bansal, Sanjay, Jonas, Maureen M., Massetto, Benedetta, Brainard, Diana M., Hsueh, Chia‐Hsiang, Shao, Jiang, Parhy, Bandita, Davison, Suzanne, Feiterna‐Sperling, Cornelia, Gillis, Lynette A., Indolfi, Giuseppe, Sokal, Etienne M., Murray, Karen F., Wirth, Stefan
Publicado 2019